Stock Events

BRAIN Biotech 

€1.52
6
-€0.07-4.4% Friday 15:30

Statistik

Tag Hoch
-
Tag Tief
-
52W Hoch
-
52W Niedrig
-
Volumen
-
Durch. Volumen
-
Marktkap.
37.03M
KGV
-
Dividendenrendite
-
Dividende
-

Demnächst

Gewinne

28MayErwartet
Q1 2022
Q2 2022
Q4 2022
Q1 2023
Q2 2023
Q4 2023
Q1 2024
999
333
-333
-999
Erwartetes EPS
K.A.
Tatsächliches EPS
K.A.

Leute folgen auch

Diese Liste basiert auf den Watchlists von Personen auf Stock Events, die BNN.XETRA folgen. Es handelt sich nicht um eine Anlageempfehlung.

Wettbewerber

Diese Liste ist eine Analyse basierend auf aktuellen Marktereignissen. Es ist keine Anlageempfehlung.

Über

BRAIN Biotech AG engages in the research and development of Bio-based products and solutions in Germany, the United States, France, the Netherlands, and the United Kingdom. It operates in three segments: BioProducts, BioScience, and BioIncubator. The company offers enzymes and biocatalysts to produce food and beverages, wound care preparations or lubricants, and production of starch and bioethanol; and microorganisms as the functional biomass for optimized industrial production processes, recycling of the greenhouse gas CO2 as an industrial raw material, and urban and green mining for extraction of precious and rare earth metals. It also provides biocatalysts and other bioactive natural compounds to produce foodstuffs and animal feed, cosmetics, and medical products, as well as for industrial applications in chemical companies, waste and hazardous materials disposal, and energy and raw materials production. The company was formerly known as B.R.A.I.N. Biotechnology Research and Information Network AG and changed its name to BRAIN Biotech AG in April 2021. BRAIN Biotech AG was founded in 1993 and is headquartered in Zwingenberg, Germany.
Show more...
CEO
Mr. Adriaan Moelker
Mitarbeiter
322
Land
DE
ISIN
DE0005203947
WKN
000520394

Börsen